- Home
- MOD vs MDGL Comparison
MOD vs MDGL Comparison
Compare MOD & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOD | MDGL |
|---|---|---|
| Founded | 1916 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 12.1B |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MOD | MDGL |
|---|---|---|
| Price | $243.69 | $523.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $223.71 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 817.1K | 293.0K |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.87 | ★ 41.32 |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $1,352,500,000.00 | $180,133,000.00 |
| Revenue This Year | $23.05 | $58.39 |
| Revenue Next Year | $21.83 | $48.55 |
| P/E Ratio | $279.94 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $77.29 | $265.00 |
| 52 Week High | $260.01 | $615.00 |
Technical Indicators
Market Signals| Indicator | MOD | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 56.39 |
| Support Level | $232.14 | $503.93 |
| Resistance Level | $260.01 | $539.17 |
| Average True Range (ATR) | 13.46 | 16.29 |
| MACD | -0.10 | -3.02 |
| Stochastic Oscillator | 52.96 | 54.30 |
Price Performance
Historical ComparisonAbout MOD Modine Manufacturing Company
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.